Stelara and CDED Diet Trial for Crohn"s Disease
Details
First posted
March 3, 2021
Diets studied
CDED
Trial type
Interventional
Sponsor
Wolfson Medical Center, Sheba Medical Center
Status
Completed
Dietary therapy involving the Crohn's disease exclusion diet (CDED) is an evolving strategy to target the microbiome and innate immunity in order to reduce inflammation and promote healing.
The goal of the current pilot study is to evaluate the added benefit of treatment with Ustekinumab combined with CDED in anti TNF exposed patients compared to treatment with Ustekinumab alone in term of achieving remission.
Support our Mission
Your donation will help us to enhance the well-being and health outcomes of patients with IBD.
Donate